Amalgamated Bank Sells 316 Shares of Teleflex Incorporated (NYSE:TFX)

Amalgamated Bank trimmed its stake in Teleflex Incorporated (NYSE:TFX) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,951 shares of the medical technology company’s stock after selling 316 shares during the period. Amalgamated Bank’s holdings in Teleflex were worth $1,593,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Avior Wealth Management LLC increased its holdings in shares of Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after buying an additional 101 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in Teleflex in the third quarter worth $40,000. True Wealth Design LLC increased its stake in Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after acquiring an additional 166 shares during the last quarter. Capital Performance Advisors LLP bought a new position in Teleflex in the third quarter valued at $54,000. Finally, Banque Cantonale Vaudoise raised its position in Teleflex by 184.8% during the third quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after purchasing an additional 146 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on TFX shares. Raymond James cut Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Finally, Wells Fargo & Company lowered their price target on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research note on Friday. Nine equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $196.83.

Teleflex Trading Down 4.7 %

NYSE:TFX opened at $132.58 on Monday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $6.16 billion, a P/E ratio of 26.36, a P/E/G ratio of 1.73 and a beta of 1.16. Teleflex Incorporated has a 52 week low of $130.60 and a 52 week high of $249.90. The company has a fifty day moving average of $175.44 and a 200 day moving average of $204.65.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. On average, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.03%. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.